Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Paul Nghiem(University of Washington Medical Center)
Cited by 197
Related Papers
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
|Clinical Cancer Research|2019|89
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
|Nature Communications|2022|56